ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2015
Tackling the threat of antimicrobial resistance: from policy to sustainable action.
Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
82 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6-step model of rational pharmacotherapy in a Turkish medical school.British journal of clinical pharmacology · 2026Article
- Species Extinction, Biodiversity, Human Health, and Inevitable Role of Lifestyle Medicine: A Narrative Review.American journal of lifestyle medicine · 2026Review
- In Vitro Antibacterial Efficacy of Cetirizine and N-Acetylcysteine Alone and in Combination with Cefalexin on Canine Methicillin-Sensitive and -ResistantPathogens (Basel, Switzerland) · 2026Article
- Repurposing lusutrombopag: unveiling anti-Staphylococcus aureus activity in a novel oral thrombopoietin receptor agonist.BMC microbiology · 2026Article
- CRISPR-Cas based plasmid design for multidrug-resistant Klebsiella pneumoniae isolates.FEMS microbiology letters · 2026Article
- Skin Microbiome Shifts in Various Dermatological Conditions.Journal of clinical medicine · 2025Review
- Status of antimicrobial resistance in food animals in Pakistan (2016-2020): A systematic review and meta-analysis.Journal of advanced veterinary and animal research · 2025Article
- Factors Influencing Community Pharmacists' Participation in Antimicrobial Stewardship: A Qualitative Inquiry.Pharmacy (Basel, Switzerland) · 2025Article
- Baohuoside I targets SaeR as an antivirulence strategy to disrupt MRSA biofilm formation and pathogenicity.NPJ biofilms and microbiomes · 2025Article
- Cost-effectiveness of screening, decolonisation and isolation strategies for carbapenem-resistant Enterobacterales and methicillin-resistantLancet regional health. Americas · 2025Article
- Antibiotic Use in Livestock and Environmental Antibiotic Resistance: A Narrative Review.Environmental health insights · 2025Review
- Utility of Artificial Intelligence in Antibiotic Development: Accelerating Discovery in the Age of Resistance.Cureus · 2025Review
- Article
- Synthesis and Antibacterial Activity of Alkylamine-Linked Pleuromutilin Derivatives.Antibiotics (Basel, Switzerland) · 2024Article
- One Health Ethics and the Ethics of Zoonoses: A Silent Call for Global Action.Veterinary sciences · 2024Review
- Autologous serum protein stabilized silver quantum clusters as host-specific antibacterial agents.Nanomedicine (London, England) · 2024Article
- Treatment and diagnosis of severe KPC-producingAnnals of medicine · 2023Article
- Early evaluation of the Food and Drug Administration (FDA) guidance on antimicrobial use in food animals on antimicrobial resistance trends reported by the National Antimicrobial Resistance Monitoring System (2012-2019).One health (Amsterdam, Netherlands) · 2023Article
- Multidrug-ResistantVeterinary sciences · 2023Article
22 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotics underpin all of modern medicine, from routine major surgery through to caesarean sections and modern cancer therapies. These drugs have revolutionized how we practice medicine, but we are in a constant evolutionary battle to evade microbial resistance and this has become a major global public health problem. We have overused and misused these essential medicines both in the human and animal health sectors and this threatens the effectiveness of antimicrobials for future generations. We can only address the threat of antimicrobial resistance (AMR) through international collaboration across human and animal health sectors integrating social, economic and behavioural factors. Our global organizations are rising to the challenge with the recent World Health Assembly resolution on AMR and development of the Global Action plan but we must act now to avoid a return to a pre-antibiotic era.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.